Tranexamic acid for post-partum haemorrhage in the WOMAN trial.

Suellen Miller, Thomas Burke, José M Belizán, Carlos Fuchtner, Andre Lalonde, Jaideep Malhorta

Abstract readLetterComment

In one paragraph

Article in Lancet (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Assessing the effect of risk factors on rates of obstetric transfusion over time using two methodological approaches.BMC medical research methodology · 2018
Article
Portuguese Consensus and Recommendations for Acquired Coagulopathic Bleeding Management (CCBM).Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Article

4 · The record

Corrections and comments

Comment on
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.2017

5 · Who and what money

Authors and funding

6 authors.

Suellen MillerDepartment of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: suellen.miller@ucsf.edu.

Thomas BurkeDepartment of Emergency Medicine, Division of Global Health and Human Rights, Massachusetts General Hospital, Boston, MA, USA.

José M BelizánDepartment of Mother and Child Health Research, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.

Carlos FuchtnerInternational Federation of Gynecology and Obstetrics, Barrio Equipetrol Norte, Santa Cruz de la Sierra, Bolivia.

Andre LalondeDepartment of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada; Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada.

Jaideep MalhortaRainbow Hospitals, Agra, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Postpartum HemorrhageTranexamic AcidAntifibrinolytic AgentsFemaleHumansPostpartum PeriodPregnancyAntifibrinolytic AgentsTranexamic Acid

Identifiers

PMID28980957

DOI10.1016/S0140-6736(17)32408-X

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.